Analysts think ANTX stock price could increase by 21%
Sep 14, 2025, 11:26 AM
-1.58%
What does ANTX do
AN2 Therapeutics, a biopharmaceutical company based in Menlo Park, California, focuses on developing treatments for serious infectious diseases, with epetraborole as a potential oral treatment for non-tuberculous mycobacterial lung disease. The company went public on March 25, 2022, and employs 41 people.
4 analysts think ANTX stock price will increase by 20.95%. The current median analyst target is $1.53 compared to a current stock price of $1.26. The lowest analysts target is $1.01 and the highest analyst target is $2.10.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.